Also found in: Medical, Encyclopedia, Wikipedia.


 (kăn′ə-bĭ-dī′ôl′, -ōl′, -ŏl′)
A nonpsychoactive constituent of cannabis, C21H30(OH)2.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

cannabidiol (CBD)

n cannabidiol m (CBD)
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
M2 PRESSWIRE-September 3, 2019-: Comprehensive Analysis Report of Global Cannabidiol (CBD) Market-Forecast,Application,Regional Trend,CAGR,Top Competitors and Business Outlook
The results of the survey indicate that overall, more than two-thirds of respondents have used or would consider using marijuana or cannabinoid compounds, including cannabidiol (CBD) and tetrahydrocannabinol, to manage pain.
ENPNewswire-August 26, 2019--NICE to work with company on addressing issues in appraisals of cannabidiol for treating difficult to control epilepsies
The National Institute for Health and Care Excellence (Nice) announced that it would not recommend cannabidiol combined with anti-seizure drug clobazam for the treatment of two types of severe epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.
Fact.MR has announced the addition of the "Cannabidiol Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2026"report to their offering.
(Alliance News) - Highlands Natural Resources PLC said on Monday that it has secured GBP354,000 through a share placing and that it is implementing cost reducing measures until the Zoetic cannabidiol product is self-sustainable.
A new study suggests that fatty foods might boost the body's absorption of cannabidiol (CBD).
Cannabidiol can weaken aggression caused by social isolation, a study has found, adding another positive factor to the growing adoption of marijuana for medical purposes.
[USA], Aug 4 (ANI): A new study has found that cannabidiol reduces aggressiveness arising out of isolation.
GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) is inching closer to clearing another regulatory hurdle with respect to its cannabidiol drug Epidiolex, potentially opening up a market opportunity in Europe.
Summary: The cannabidiol marketplace is likely to witness significant R&D investment in the pharmaceutical industry as a broad-spectrum pharmaceutical therapeutics.